Form 8-K - Current report:
SEC Accession No. 0001213900-26-021120
Filing Date
2026-02-27
Accepted
2026-02-27 09:14:34
Documents
70
Period of Report
2026-02-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea02262026-8k_inmune.htm   iXBRL 8-K 25598
2 INVESTOR PRESENTATION ea0226202601_ex99-1.htm EX-99.1 63055
3 GRAPHIC ea0226202601_ex99-1img1.jpg GRAPHIC 283666
4 GRAPHIC ea0226202601_ex99-1img2.jpg GRAPHIC 388023
5 GRAPHIC ea0226202601_ex99-1img3.jpg GRAPHIC 650868
6 GRAPHIC ea0226202601_ex99-1img4.jpg GRAPHIC 253122
7 GRAPHIC ea0226202601_ex99-1img5.jpg GRAPHIC 271040
8 GRAPHIC ea0226202601_ex99-1img6.jpg GRAPHIC 242045
9 GRAPHIC ea0226202601_ex99-1img7.jpg GRAPHIC 228223
10 GRAPHIC ea0226202601_ex99-1img8.jpg GRAPHIC 232500
11 GRAPHIC ea0226202601_ex99-1img9.jpg GRAPHIC 307928
12 GRAPHIC ea0226202601_ex99-1img10.jpg GRAPHIC 196839
13 GRAPHIC ea0226202601_ex99-1img11.jpg GRAPHIC 240166
14 GRAPHIC ea0226202601_ex99-1img12.jpg GRAPHIC 241898
15 GRAPHIC ea0226202601_ex99-1img13.jpg GRAPHIC 130270
16 GRAPHIC ea0226202601_ex99-1img14.jpg GRAPHIC 143146
17 GRAPHIC ea0226202601_ex99-1img15.jpg GRAPHIC 216977
18 GRAPHIC ea0226202601_ex99-1img16.jpg GRAPHIC 135356
19 GRAPHIC ea0226202601_ex99-1img17.jpg GRAPHIC 173084
20 GRAPHIC ea0226202601_ex99-1img18.jpg GRAPHIC 170072
21 GRAPHIC ea0226202601_ex99-1img19.jpg GRAPHIC 202163
22 GRAPHIC ea0226202601_ex99-1img20.jpg GRAPHIC 262856
23 GRAPHIC ea0226202601_ex99-1img21.jpg GRAPHIC 160856
24 GRAPHIC ea0226202601_ex99-1img22.jpg GRAPHIC 164777
25 GRAPHIC ea0226202601_ex99-1img23.jpg GRAPHIC 200289
26 GRAPHIC ea0226202601_ex99-1img24.jpg GRAPHIC 191578
27 GRAPHIC ea0226202601_ex99-1img25.jpg GRAPHIC 310015
28 GRAPHIC ea0226202601_ex99-1img26.jpg GRAPHIC 202303
29 GRAPHIC ea0226202601_ex99-1img27.jpg GRAPHIC 232645
30 GRAPHIC ea0226202601_ex99-1img28.jpg GRAPHIC 200045
31 GRAPHIC ea0226202601_ex99-1img29.jpg GRAPHIC 370249
32 GRAPHIC ea0226202601_ex99-1img30.jpg GRAPHIC 210341
33 GRAPHIC ea0226202601_ex99-1img31.jpg GRAPHIC 264050
34 GRAPHIC ea0226202601_ex99-1img32.jpg GRAPHIC 209592
35 GRAPHIC ea0226202601_ex99-1img33.jpg GRAPHIC 251136
36 GRAPHIC ea0226202601_ex99-1img34.jpg GRAPHIC 201648
37 GRAPHIC ea0226202601_ex99-1img35.jpg GRAPHIC 207901
38 GRAPHIC ea0226202601_ex99-1img36.jpg GRAPHIC 241871
39 GRAPHIC ea0226202601_ex99-1img37.jpg GRAPHIC 180445
40 GRAPHIC ea0226202601_ex99-1img38.jpg GRAPHIC 303506
41 GRAPHIC ea0226202601_ex99-1img39.jpg GRAPHIC 215808
42 GRAPHIC ea0226202601_ex99-1img40.jpg GRAPHIC 261199
43 GRAPHIC ea0226202601_ex99-1img41.jpg GRAPHIC 157506
44 GRAPHIC ea0226202601_ex99-1img42.jpg GRAPHIC 182974
45 GRAPHIC ea0226202601_ex99-1img43.jpg GRAPHIC 249194
46 GRAPHIC ea0226202601_ex99-1img44.jpg GRAPHIC 128374
47 GRAPHIC ea0226202601_ex99-1img45.jpg GRAPHIC 213112
48 GRAPHIC ea0226202601_ex99-1img46.jpg GRAPHIC 185501
49 GRAPHIC ea0226202601_ex99-1img47.jpg GRAPHIC 172113
50 GRAPHIC ea0226202601_ex99-1img48.jpg GRAPHIC 247780
51 GRAPHIC ea0226202601_ex99-1img49.jpg GRAPHIC 259303
52 GRAPHIC ea0226202601_ex99-1img50.jpg GRAPHIC 161420
53 GRAPHIC ea0226202601_ex99-1img51.jpg GRAPHIC 233743
54 GRAPHIC ea0226202601_ex99-1img52.jpg GRAPHIC 441957
55 GRAPHIC ea0226202601_ex99-1img53.jpg GRAPHIC 251464
56 GRAPHIC ea0226202601_ex99-1img54.jpg GRAPHIC 182811
57 GRAPHIC ea0226202601_ex99-1img55.jpg GRAPHIC 146315
58 GRAPHIC ea0226202601_ex99-1img56.jpg GRAPHIC 153284
59 GRAPHIC ea0226202601_ex99-1img57.jpg GRAPHIC 204097
  Complete submission text file 0001213900-26-021120.txt   18349064

Data Files

Seq Description Document Type Size
60 XBRL SCHEMA FILE inmb-20260227.xsd EX-101.SCH 3017
61 XBRL LABEL FILE inmb-20260227_lab.xml EX-101.LAB 34239
62 XBRL PRESENTATION FILE inmb-20260227_pre.xml EX-101.PRE 22360
72 EXTRACTED XBRL INSTANCE DOCUMENT ea02262026-8k_inmune_htm.xml XML 3207
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 26693106
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)